Abstract: Methods and apparatus to interface an application to a database are disclosed. An example method includes determining a query used by an application that is to communicate with a database via a database driver. The query is tested on the database via the database driver. Such testing includes storing a query template when a received result of the query matches an expected result of the query. A database access framework is generated to interface between the application and the database driver based on the stored query template.

Abstract: A user-friendly system, method, and program product for installing an image on a computer, the method comprising: booting the computer (400) from an image source; receiving first information from an end-user of the computer (400), wherein the first information is at least one unique identifier associated with the end-user; obtaining automatically second information associated with the end-user based on the first information; determining automatically if there is an existing record associated with the computer based on the second information; renewing automatically, if there is an existing record associated with the computer, a computer account in a directory service based on the existing record; creating automatically, if there is not an existing record associated with the computer, a new computer account in the directory service; installing automatically the image to the computer; and joining automatically the computer to directory service domain based on the newly created computer account or based on the re

Abstract: A system, method, and program product comprise a user profile, a remote storage device and a user computer with a memory. A user copy of the user profile is stored in the memory of the user computer. A user profile synchronization component synchronizes the user copy of the user profile with a backup copy of the user profile at the remote storage device. A user profile download component allows a user to selectively download the backup copy of the user profile from the remote storage device.

Abstract: A glove for gardening and other general utility uses is provided comprising a palm portion configured to substantially cover a user's palm and palm side surface of the user's fingers and thumb, and a back portion configured to substantially cover the back of a user's hand and back surface of the user's fingers and thumb. One or more gripping portions are provided on the palm portion, with the back portion and the gripping portion comprising the same design pattern. Alternatively, the back portion and the gripping portions may comprise different design patterns. The design pattern or patterns are intended to be aesthetically pleasing, with the pattern on the gripping portions also aiding in the functionality of the glove by improving gripping and dexterity.

Abstract: The present invention relates to data backup, and specifically to an apparatus, method, and computer readable medium to manage and automate the backup and synchronization of data on client machines and servers. For example, the system includes a user computer that contains local files and a data repository to which those local files are backed up and synchronized. A user is able to monitor and control the synchronization of the files. The files on the user computer are initially accessed. The files stored in the data repository can be utilized to update the local files, if necessary.

Abstract: A halogen lamp assembly 20 for a substrate processing chamber 100 has a halogen lamp 22 and a ceramic heat sink monolith 24. The halogen lamp 22 includes a filament 28 and a pair of electrical connectors 30 encapsulated in an envelope 26 having a pinch seal end 34. The ceramic heat sink monolith 24 includes a block 38 and an array of spaced apart posts 40 projecting outwardly from the block 38. The block 38 includes a cavity 42 that has a recessed inner surface 44 shaped to mate with the pinch seal end 34 of the lamp 22 and an opening that allows the electrical connectors 30 of the halogen lamp 22 to pass through.

Abstract: Described herein are compounds that are useful as ERK2 inhibitors. These compounds, and pharmaceutically acceptable compositions thereof, are useful for treating or lessening the severity of a variety of disorders, including proliferative disorders such as cancer.

Abstract: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Abstract: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Abstract: Described herein are compounds that are useful as protein kinase inhibitors having the formula: wherein Z1 and Z2 are each independently nitrogen or CH and Ring A, TmR1, QR2, UnR3, and Sp are as described in the specification. The compounds are especially useful as inhibitors of ERK2 and for treating diseases in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, diabetes, and cardiovascular disease.

Abstract: A device, system and method of data compression are provided. The invention includes a receiving module that may be a memory module. The invention also includes a pointer module storing a pointer to a location within the receiving module. The invention allocates a receiving space within the receiving module and associates the pointer with the receiving space. The pointer may be associated with the beginning of the receiving space. The invention compresses a first data block and directs the compressed first data block to the receiving space at the location indicated by the pointer. The invention further associates the pointer with the location in the receiving space contiguous with the received compressed first data block. The invention compresses a second data block and directs the compressed second data block to the location within the receiving space indicated by the pointer. The invention compresses data as contiguous compressed data blocks.

Abstract: Described herein are compounds that are useful as protein kinase inhibitors having the formula: wherein Z1 and Z2 are each independently nitrogen or CH and Ring A, TmR1, QR2, UnR3, and Sp are as described in the specification. The compounds are especially useful as inhibitors of ERK2 and for treating diseases in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, diabetes, and cardiovascular disease.

Abstract: Described herein are compounds that are useful as protein kinase inhibitors of formula I: or a pharmaceutically acceptable salt thereof, wherein Ring B, Z1, Z2, U, p, Q, R1, R2, R3, and R3 are as defined herein. These compounds, and pharmaceutically acceptable compositions thereof, are useful for treating or lessening the severity of a variety of disorders, including stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplantation.

Abstract: The present invention provides compounds of formula I: where R1 is H, CONH2, T(n)-R, or T(n)-Ar2, n may be zero or one, and G, XYZ, and Q are as described below. These compounds are inhibitors of protein kinase, particularly inhibitors of JNK, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.

Abstract: The present invention relates to a novel class of sulfonamides which are aspartyl protease inhibitors. In one embodiment, this invention relates to a novel class of HIV aspartyl protease inhibitors characterized by specific structural and physicochemical features. This invention also relates to pharmaceutical compositions comprising these compounds. The compounds and pharmaceutical compositions of this invention are particularly well suited for inhibiting HIV-1 and HIV-2 protease activity and consequently, may be advantageously used as anti-viral agents against the HIV-1 and HIV-2 viruses. This invention also relates to methods For inhibiting the activity of HIV aspartyl protease using the compounds of this invention and methods for screening compounds for anti-HIV activity.

Abstract: Described herein are compounds that are useful as ERK2 inhibitors. These compounds, and pharmaceutically acceptable compositions thereof, are useful for treating or lessening the severity of a variety of disorders, including proliferative disorders such as cancer.

Abstract: Described herein are compounds that are useful as protein kinase inhibitors of formula I: or a pharmaceutically acceptable salt thereof, wherein Ring A, Z1, Z2, U, Q, R1, R2, and L are as defined herein. These compounds, and pharmaceutically acceptable compositions thereof, are useful for treating or lessening the severity of a variety of disorders, including proliferative disorders such as cancer.

Abstract: Described herein are compounds that are useful as protein kinase inhibitors having the formula: where R1-4, Q, and T are described in the specification. The compounds are useful for treating disease states in mammals that are alleviated by a protein kinase inhibitor, particularly diseases such as cancer, inflammatory disorders, restenosis, and cardiovascular disease.

Abstract: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.

Abstract: The present invention relates to compounds useful of inhibitors of protein kinases. The invention also provides pharmaceutically acceptable compositions comprising said compounds and methods of using the compositions in the treatment of various disease, conditions, or disorders.